Download Files:
Oxaprozin
SKU
HY-B0808-10 mg
Category Reference compound
Tags Akt;Apoptosis;COX;IKK;NF-κB, Apoptosis;Immunology/Inflammation;NF-κB;PI3K/Akt/mTOR, Inflammation/Immunology; Cancer
$25 – $130
Products Details
Product Description
– Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].
Web ID
– HY-B0808
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C18H15NO3
References
– [1]Ottonello L, et al. Delayed apoptosis of human monocytes exposed to immune complexes is reversed byoxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway. Br J Pharmacol. 2009 May;157(2):294-306.|[2]Montecucco F, et al. Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways. J Biomed Biotechnol. 2009;2009:478785.
CAS Number
– 21256-18-8
Molecular Weight
– 293.32
Compound Purity
– 99.95
SMILES
– O=C(O)CCC1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)O1
Clinical Information
– Launched
Research Area
– Inflammation/Immunology; Cancer
Solubility
– DMSO : ≥ 100 mg/mL
Target
– Akt;Apoptosis;COX;IKK;NF-κB
Isoform
– COX-1;COX-2;IKK;NF-κB
Pathway
– Apoptosis;Immunology/Inflammation;NF-κB;PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.